IL98387A0 - Pyridyl-benzoic acid derivatives for treating leukotriene-related diseases - Google Patents
Pyridyl-benzoic acid derivatives for treating leukotriene-related diseasesInfo
- Publication number
- IL98387A0 IL98387A0 IL98387A IL9838791A IL98387A0 IL 98387 A0 IL98387 A0 IL 98387A0 IL 98387 A IL98387 A IL 98387A IL 9838791 A IL9838791 A IL 9838791A IL 98387 A0 IL98387 A0 IL 98387A0
- Authority
- IL
- Israel
- Prior art keywords
- pyridyl
- benzoic acid
- acid derivatives
- related diseases
- treating leukotriene
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53439790A | 1990-06-07 | 1990-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL98387A0 true IL98387A0 (en) | 1992-07-15 |
Family
ID=24129867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL98387A IL98387A0 (en) | 1990-06-07 | 1991-06-05 | Pyridyl-benzoic acid derivatives for treating leukotriene-related diseases |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0593464A1 (fr) |
| JP (1) | JPH07116150B2 (fr) |
| KR (1) | KR930700102A (fr) |
| CN (1) | CN1058015A (fr) |
| AU (1) | AU655428B2 (fr) |
| CA (1) | CA2083957A1 (fr) |
| FI (1) | FI925545A (fr) |
| HU (1) | HUT64747A (fr) |
| IL (1) | IL98387A0 (fr) |
| MA (1) | MA22195A1 (fr) |
| MX (1) | MX26167A (fr) |
| NZ (1) | NZ238426A (fr) |
| PL (1) | PL290587A1 (fr) |
| PT (1) | PT97913A (fr) |
| TW (1) | TW221809B (fr) |
| WO (1) | WO1991018601A1 (fr) |
| ZA (1) | ZA914322B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0604529A1 (fr) * | 1991-09-19 | 1994-07-06 | Smithkline Beecham Corporation | Composes de pyridine utilises dans le traitement des maladies apparentees aux leucotrienes |
| IL106156A0 (en) * | 1992-06-30 | 1993-10-20 | Smithkline Beecham Corp | Pyridinyl compounds |
| MX9303972A (es) * | 1992-06-30 | 1994-04-29 | Smithkline Beecham Corp | Procedimiento para hacer compuestos de tioeter. |
| DE4224402A1 (de) * | 1992-07-21 | 1994-01-27 | Schering Ag | Neue Pyridin-Derivate mit Leukotrien-B¶4¶-antagonistischer Wirkung |
| GR1001409B (el) * | 1992-10-15 | 1993-11-30 | Smithkline Beecham Corp | Ενώσεις για την ?εραπευτική αγωγή ασ?ενειών που έχουν σχέση με λευκοτριένια. |
| ES2065234B1 (es) * | 1992-10-27 | 1995-09-01 | Smithkline Beecham Corp | Compuestos para tratar enfermedades relacionadas con los leucotrienos. |
| US5643914A (en) * | 1993-03-02 | 1997-07-01 | Smithkline Beecham Corporation | Pharmaceutical pyridine compounds |
| US5929096A (en) * | 1996-02-29 | 1999-07-27 | Smithkline Beecham Corporation | Method for treating atopic dermatitis and contact dermatitis |
| CA2265996A1 (fr) * | 1996-09-26 | 1998-04-02 | Roger Aki Fujimoto | Acrylamides substitues par de l'aryle ayant une activite antagoniste du recepteur leucotriene b4 (ltb-4) |
| EP3192872A1 (fr) | 2003-08-26 | 2017-07-19 | The Regents of the University of Colorado, a body corporate | Inhibiteurs de l'activité de sérine protéase et leur utilisation dans les procédés et compositions pour le traitement des infections bactériennes |
| EP3812363B1 (fr) * | 2018-06-22 | 2022-08-03 | Panasonic Holdings Corporation | Sel organique, capteur de radicaux hydroxy le comprenant, et milieu de détection |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4056619A (en) * | 1975-09-08 | 1977-11-01 | Warner-Lambert Company | 1-Substituted-2-(2-pyridinyl)ethanone N-oxides |
-
1991
- 1991-05-31 HU HU9203867A patent/HUT64747A/hu unknown
- 1991-05-31 KR KR1019920703091A patent/KR930700102A/ko active IP Right Grant
- 1991-05-31 WO PCT/US1991/003772 patent/WO1991018601A1/fr not_active Application Discontinuation
- 1991-05-31 CA CA002083957A patent/CA2083957A1/fr not_active Abandoned
- 1991-05-31 JP JP3511468A patent/JPH07116150B2/ja not_active Expired - Lifetime
- 1991-05-31 EP EP91911699A patent/EP0593464A1/fr not_active Ceased
- 1991-05-31 AU AU81896/91A patent/AU655428B2/en not_active Ceased
- 1991-06-03 MA MA22441A patent/MA22195A1/fr unknown
- 1991-06-05 IL IL98387A patent/IL98387A0/xx unknown
- 1991-06-06 NZ NZ238426A patent/NZ238426A/en unknown
- 1991-06-06 TW TW080104434A patent/TW221809B/zh active
- 1991-06-06 ZA ZA914322A patent/ZA914322B/xx unknown
- 1991-06-07 CN CN91104563A patent/CN1058015A/zh active Pending
- 1991-06-07 PT PT97913A patent/PT97913A/pt not_active Application Discontinuation
- 1991-06-07 MX MX2616791A patent/MX26167A/es unknown
- 1991-06-07 PL PL29058791A patent/PL290587A1/xx unknown
-
1992
- 1992-12-07 FI FI925545A patent/FI925545A/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW221809B (fr) | 1994-03-21 |
| JPH07116150B2 (ja) | 1995-12-13 |
| FI925545A0 (fi) | 1992-12-07 |
| KR930700102A (ko) | 1993-03-13 |
| CN1058015A (zh) | 1992-01-22 |
| HU9203867D0 (en) | 1993-03-29 |
| EP0593464A4 (fr) | 1993-02-12 |
| AU655428B2 (en) | 1994-12-22 |
| MX26167A (es) | 1994-02-28 |
| PT97913A (pt) | 1992-03-31 |
| HUT64747A (en) | 1994-02-28 |
| ZA914322B (en) | 1992-06-24 |
| NZ238426A (en) | 1994-11-25 |
| AU8189691A (en) | 1991-12-31 |
| FI925545A (fi) | 1992-12-07 |
| JPH05507492A (ja) | 1993-10-28 |
| MA22195A1 (fr) | 1992-04-01 |
| WO1991018601A1 (fr) | 1991-12-12 |
| PL290587A1 (en) | 1992-08-24 |
| CA2083957A1 (fr) | 1991-12-08 |
| EP0593464A1 (fr) | 1994-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU907339D0 (en) | Process for treating diseases | |
| IL103126A0 (en) | 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents | |
| ZA914001B (en) | Essential fatty acid treatment | |
| HU9501923D0 (en) | Substituted azolone derivatives for treating diseases caused by helicobacter | |
| AP9200428A0 (en) | Compounds for treating leukotriene-related diseases | |
| ZA93190B (en) | Benzofuranyl- and thiophenylmethylthio-alkanecarboxylic acid derivatives | |
| ZA914322B (en) | Pyridyl-benzoic acid derivatives for treating leukotrienerelated diseases | |
| IL98388A0 (en) | Benzoic acid derivatives for treating leukotriene-related diseases | |
| ZA914369B (en) | Amide linked pyridyl-benzoic acid derivatives for treating leukotriene-related diseases | |
| EP0444156A4 (en) | Method for treating vascular diseases | |
| EP0421752A3 (en) | Substituted acrylamido-penicillanic acid derivatives | |
| CS22891A2 (en) | Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases | |
| ZA931367B (en) | Sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives | |
| IL97210A0 (en) | Process for the preparation of 7-amino-3-methoxymethyl-ceph-3-em-carboxylic acid | |
| ZA93125B (en) | Quinolone- and naphthyridone-carboxylic acid derivatives | |
| NO924701D0 (no) | Amid-bundete pyridyl-benzosyrederivater for behandling avleukotrien-relaterte sykdommer | |
| HU905999D0 (en) | Process for the preparation of rodanido-isobutyric acid | |
| HUT57734A (en) | Process for producing pyrazaolecarboxylic acid derivatives | |
| ZA903999B (en) | Mevinic acid derivatives | |
| GB8809871D0 (en) | -amino-alkanoic acid derivative & processes | |
| NO924702D0 (no) | Pyridyl-benzosyrederivater for behandling av leukotrien-relaterte sykdommer | |
| EP0446925A3 (en) | Process for the preparation of beta-resorcylic acid derivatives | |
| ZA926938B (en) | Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents | |
| IE901971L (en) | Mevinic acid derivatives | |
| IE901047L (en) | Thienylacetic acid derivatives |